Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;17(3):165-70.
doi: 10.1038/gene.2016.4. Epub 2016 Jan 28.

TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus

S Wang  1   2   3 , F Wen  1   4 , K L Tessneer  1 , P M Gaffney  1
Affiliations

TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus

S Wang et al. Genes Immun. 2016 Apr.

Abstract

Linkage disequilibrium poses a major challenge to the functional characterization of specific disease-associated susceptibility variants. Precision genome-editing technologies have provided new opportunities to address this challenge. As proof of concept, we employed TALEN (transcription activation-like effector nuclease)-mediated genome editing to specifically disrupt the TT>A enhancer region to mimic candidate causal variants identified in the systemic lupus erythematosus-associated susceptibility gene, tumor necrosis factor-α-induced protein 3 (TNFAIP3), in an isogenic HEK293T cell line devoid of other linkage disequilibrium-associated variants. Targeted disruption of the TT>A enhancer impaired its interaction with the TNFAIP3 promoter by long-range DNA looping, thereby reducing TNFAIP3 gene expression. Loss of TNFAIP3 mRNA and its encoded protein, A20, impaired tumor necrosis factor-α-induced receptor-mediated downregulation of nuclear factor-κB signaling, a hallmark of autoimmunity. Results demonstrate that the TT>A enhancer variants contribute to causality and function independently of other variants to disrupt TNFAIP3 expression. Furthermore, we believe this approach can be implemented to independently examine other candidate casual variants in the future.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1. Design of TALENs for targeting the TT>A enhancer
A. Location of 5’ and 3’ TALEN nuclease binding sites. B. Western blotting of transfected HA-tagged 5’ TALEN arm and FLAG-tagged 3’ TALEN arm in HEK293T cells. C. Location of TALEN-mediated mutations of the TT>A enhancer in two HEK293T cell lines. Mutant 1 has a 26 base pair deletion of the TT>A enhancer including the NF-κB and SATB1 binding sites. Mutant 2 has a 9 base pair deletion and 4 base pair insertion (indel) of the TT>A enhancer that disrupts the NF-κB binding site. Red letters in A and C indicate the SLE risk TT>A polymorphisms.
Figure 2
Figure 2. Mutating the TT>A enhancer region by TALEN engineering impairs TNFAIP3 expression
A. Quantitative RT-PCR analysis of TNFAIP3 mRNA expression normalized to control HMBS mRNA in control and clonal mutant HEK293T cell lines. B. Western blotting analysis of A20 protein normalized to β-actin in parental (control) and clonal mutant HEK293T cell lines. Statistical significance was calculated using paired student t-test. For all experiments: n = 3, *p < 0.05.
Figure 3
Figure 3. TALEN mutagenesis of the TT>A enhancer reduces interaction with the TNFAIP3 promoter
A. Schematic representation of the allele-specific 3C and clonal assay analyses of the engineered heterozygous clonal mutant HEK293T cell lines. Wild type (WT) allele experiences higher frequencies of long-range DNA looping, thus higher proportions of 3C events are observed relative to Mutant 1 or Mutant 2 alleles. B. Genomic DNA isolated from 72 clonal expansions from Mutant 1 or Mutant 2 HEK293T cells without 3C was analyzed for wild type and mutant allele frequencies. The expected clonal frequency of approximately 50% wild type and 50% mutant allele was observed. C. Analysis of 72 mutant 1 or 2 clonal expansions from the 3C capture were analyzed for relative crosslinking frequencies between wild-type or mutated TT>A enhancer and TNFAIP3 promoter. P values were calculated using the Fisher’s exact test and are as indicated.
Figure 4
Figure 4. TALEN mutagenesis of the TT>A enhancer region delayed TNFα-inducible inactivation of NF-κB signaling
A. Western blotting of phospho-IκBα at designated time points following TNFα stimulation of parental (wild type) and clonal mutant HEK293T cells. B. Densitometry analyses of Western blotting data represented in (A) normalized to β-actin levels; n = 3, P value calculated by two-way ANOVA and are as indicated.
Figure 5
Figure 5. SLE-associated TT>A enhancer risk allele is causal for SLE-associated A20 protein reduction and elevated NF-κB signaling
Schematic depiction of the TT>A enhancer function in non-risk and SLE-associated risk alleles. SLE-associated polymorphisms in the TT>A enhancer impairs long-range DNA looping and TT>A enhancer interaction with, and delivery of transcription factors including NF-κB, to the TNFAIP3 gene promoter. Subsequent reductions in TNFAIP3 mRNA transcription and A20 protein translation impair A20-mediated ubiquitination and degradation of NF-κB, thus preventing attenuation of pro-inflammatory NF-κB signaling.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cui Y, Sheng Y, Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun. 2013;41:25–33. - PubMed
    1. Relle M, Weinmann-Menke J, Scorletti E, Cavagna L, Schwarting A. Genetics and novel aspects of therapies in systemic lupus erythematosus. Autoimmun Rev. 2015 - PubMed
    1. Adrianto I, Wang S, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum. 2012;64(11):3695–3705. - PMC - PubMed
    1. Wang S, Adrianto I, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun. 2012;13(5):380–387. - PMC - PubMed
    1. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008;40(9):1059–1061. - PMC - PubMed

Publication types